Universal Cells
Katie Lombardo currently holds the position of Associate Director, Research, Gene Editing at Universal Cells. Prior to this role, Katie worked as a Senior Scientist at the same company. Katie has experience as a Scientist II and Scientist I at the Fred Hutchinson Cancer Research Center. Katie also completed an externship at Omeros Corporation where Katie worked in the robotics division. Katie holds a Doctor of Philosophy (PhD) in Molecular & Cellular Biology from the University of Washington and a Bachelor of Science (B.S.) in Biological Sciences from the University of Southern California.
Universal Cells
Universal Cells is a Seattle-based biotech developing, licensing and commercializing stem cell therapies that overcome immune rejection and can be used to create true off-the-shelf therapeutic products. Using the company's proprietary genome editing approach, the company engineers stem cells to prevent expression of polymorphic human leukocyteantigen (HLA) molecules, removing the cause of donor tissue rejection and creating Universal Donor Stem Cells that are compatible with every patient.